ID
45533
Descrizione
Principal Investigator: Jose Florez, Massachusetts General Hospital, Boston, MA, USA MeSH: Diabetes Mellitus, Type 2 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000681 The Diabetes Prevention Program (DPP) was a multicenter controlled clinical trial examining the efficacy of an intensive lifestyle intervention or metformin to prevent or delay the development of diabetes in a population selected to be at high risk due to the presence of impaired glucose tolerance (IGT) and obesity. Development of diabetes, defined by 1997 American Diabetes Association (ADA) criteria, was the primary outcome while cardiovascular disease and its risk factors were important secondary outcomes. The pharmacological intervention was double blinded and placebo controlled. After randomization, participants had quarterly clinical evaluations and had, in addition, a fasting plasma glucose at semi-annual visits and a 75 gram oral glucose tolerance test at annual visits. Volunteers were recruited from populations known to be at particularly high risk for impaired glucose tolerance and type 2 diabetes including the following: persons with a family history of NIDDM, the elderly, overweight individuals, women with a history of diabetes during pregnancy ("gestational diabetes"), and minority populations including African Americans, Hispanic Americans, Asian and Pacific Island Americans, and Native Americans. The primary focus of the genetic investigations have been on candidate genes, including candidates derived from GWAS of diabetes, lipid and glycemia-related phenotypes. *Please note* more phenotype data for the DPPG cohort is available through the NIDDK Data Repository. Information on obtaining this phenotype data can be found by going to https://www.niddkrepository.org/studies/dppos/?query=DPP and https://www.niddkrepository.org/studies/dpp/?query=DPP. Data will need to be requested from both data sets. A linking file will be available to the NIDDK Data Repository.
collegamento
Keywords
versioni (1)
- 28/12/22 28/12/22 - Simon Heim
Titolare del copyright
Jose Florez, Massachusetts General Hospital, Boston, MA, USA
Caricato su
28 dicembre 2022
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs000681 Diabetes Prevention Program Genetics (DPPG)
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants involved in the "Common Variation in Candidate Genes in the Diabetes Prevention Program" project.
- Subject ID, sample ID, and sample use variable obtained from participants involved in the "Common Variation in Candidate Genes in the Diabetes Prevention Program" project.
- Subject ID, age, sex, race, and BMI of participants involved in the "Common Variation in Candidate Genes in the Diabetes Prevention Program" project.
- Sample ID, body site, analyte type, and tumor status of samples obtained from participants involved in the "Common Variation in Candidate Genes in the Diabetes Prevention Program" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants involved in the "Common Variation in Candidate Genes in the Diabetes Prevention Program" project.
- Subject ID, sample ID, and sample use variable obtained from participants involved in the "Common Variation in Candidate Genes in the Diabetes Prevention Program" project.
- Subject ID, age, sex, race, and BMI of participants involved in the "Common Variation in Candidate Genes in the Diabetes Prevention Program" project.
- Sample ID, body site, analyte type, and tumor status of samples obtained from participants involved in the "Common Variation in Candidate Genes in the Diabetes Prevention Program" project.
C0680251 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,2])
C0680251 (UMLS CUI [1,3])
C0271650 (UMLS CUI [1,4])
C0017741 (UMLS CUI [1,5])
C0001779 (UMLS CUI [1,6])
C1305855 (UMLS CUI [1,7])
C0348080 (UMLS CUI [1,8])
C0087111 (UMLS CUI [1,9])
C0521102 (UMLS CUI [1,10])
C0030699 (UMLS CUI [1,11])
C0947630 (UMLS CUI [1,12])